Oral Atogepant May Prevent Episodic Migraine in Adults
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Lancet Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety, Tolerability, and Efficacy of Orally Administered Atogepant for the Prevention of Episodic Migraine in Adults: A Double-Blind, Randomised Phase 2b/3 Trial
Lancet Neurol 2020 Sep 01;19(9)727-737, PJ Goadsby, DW Dodick, J Ailani, JM Trugman, M Finnegan, K Lu, A SzegediFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.